Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Lilja

Showing results (11-20 of 306) with videos related to

Pageof 31
Sort By:
Clinical Chemistry|January 4, 2024
Eight Misconceptions about Prostate-Specific AntigenAndrew J Vickers, Hans Lilja
Clinical Chemistry|November 26, 2008
Cutpoints in clinical chemistry: time for fundamental reassessmentAndrew J Vickers, Hans Lilja
European Urology|December 16, 2011
PSA is dead, long live PSAAndrew J Vickers, Hans Lilja
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 2026
Evaluation of the 4Kscore in EPIC: LetterAndrew J Vickers, Hans Lilja
Urology|December 27, 2011
We need a better marker for prostate cancer. How about renaming PSA?Andrew J Vickers, Hans Lilja
Clinical Chemistry|November 22, 2018
Perspective on Prostate Cancer ScreeningSigrid V Carlsson, Hans Lilja
World Journal of Urology|November 22, 2011
Predicting prostate cancer many years before diagnosis: how and why?Andrew J Vickers, Hans Lilja
The Urologic Clinics of North America|April 15, 2014
Emerging PSA-based tests to improve screeningRichard J Bryant, Hans Lilja
Nature Reviews. Clinical Oncology|November 30, 2011
Urological cancer: Time for another rethink on prostate cancer screeningAndrew J Vickers, Hans Lilja
Asian Journal of Urology|December 30, 2025
Five things you need to know about prostate cancer diagnostic testsAndrew J Vickers, Hans Lilja
Pageof 31

Showing results (11-20 of 306) with videos related to

Sort By:
Pageof 31
Clinical Chemistry|January 4, 2024
Eight Misconceptions about Prostate-Specific AntigenAndrew J Vickers, Hans Lilja
Clinical Chemistry|November 26, 2008
Cutpoints in clinical chemistry: time for fundamental reassessmentAndrew J Vickers, Hans Lilja
European Urology|December 16, 2011
PSA is dead, long live PSAAndrew J Vickers, Hans Lilja
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 2026
Evaluation of the 4Kscore in EPIC: LetterAndrew J Vickers, Hans Lilja
Urology|December 27, 2011
We need a better marker for prostate cancer. How about renaming PSA?Andrew J Vickers, Hans Lilja
Clinical Chemistry|November 22, 2018
Perspective on Prostate Cancer ScreeningSigrid V Carlsson, Hans Lilja
World Journal of Urology|November 22, 2011
Predicting prostate cancer many years before diagnosis: how and why?Andrew J Vickers, Hans Lilja
The Urologic Clinics of North America|April 15, 2014
Emerging PSA-based tests to improve screeningRichard J Bryant, Hans Lilja
Nature Reviews. Clinical Oncology|November 30, 2011
Urological cancer: Time for another rethink on prostate cancer screeningAndrew J Vickers, Hans Lilja
Asian Journal of Urology|December 30, 2025
Five things you need to know about prostate cancer diagnostic testsAndrew J Vickers, Hans Lilja
Pageof 31